TD-1607 SAD Study in Healthy Subjects

Clinical trial NCT01791049 · COMPLETED

Trial details

NCT number: NCT01791049
Sponsor: Theravance Biopharma
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Serious Infections Due to Known or Suspected Gram-positive Pathogens

Start date: 2013-04-01
Primary completion: 2013-08-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.